Bottom line
Is JAVTX a good fund? The bottom line
JAVTX is the Class T share class of Janus Henderson Venture Fund, an actively managed large blend mutual fund from Janus Henderson.
Its expense ratio is 0.92% — about $92 a year on every $10,000 invested, more expensive than 57% of large blend funds we track.
With $3.6 billion in net assets and 175 holdings, its largest position is Glaukos Corp. (2.6%) and the top 10 make up 20.1% of the portfolio.
What stands out
- No front-end sales load
Updated Nov 19, 2026
What JAVTX invests in
Janus Henderson Venture Fund seeks capital appreciation.
The Fund pursues its investment objective by investing at least 50% of its net assets in small-sized companies. The Fund may also invest in larger companies with strong growth potential. Small-sized companies are defined by portfolio management as those companies whose market capitalization falls within the 12-month capitalization range of the Russell 2000 Growth Index at the time of purchase. Market capitalization is a commonly used measure of the size and value of a company. The market capitalizations within the index will vary, but as of September 30, 2025, they ranged from approximately $4 million to $21.31 billion. The Fund may invest in shares of companies through initial public offerings and secondary offerings. Portfolio management applies a bottom-up approach in choosing investments. In other words, portfolio management looks at companies one at a time to determine if a…
From the fund's prospectus (filed Jan 28, 2026).
JAVTX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| JAVTX | — | — | — |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of
What JAVTX costs
On a $10,000 investment, JAVTX's 0.92% expense ratio costs about $92 a year. The prospectus estimates $1,131 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
JAVTX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Glaukos Corp. | 2.59% |
| 2 | Ligand Pharmaceuticals, Inc. | 2.41% |
| 3 | Perimeter Solutions, Inc. | 2.19% |
| 4 | SPX Technologies, Inc. | 2.12% |
| 5 | Revolution Medicines, Inc. | 1.99% |
| 6 | Tower Semiconductor Ltd. | 1.89% |
| 7 | CECO Environmental Corp. | 1.87% |
| 8 | Legence Corp. | 1.73% |
| 9 | Casey's General Stores, Inc. | 1.70% |
| 10 | Janus Henderson Cash Liquidity Fund LLC | 1.64% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 20.1% of the fund. See all top 25 holdings and asset mix →